130 related articles for article (PubMed ID: 6188035)
1. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
Olianas MC; Onali P; Neff NH; Costa E
Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
3. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart.
Olianas MC; Onali P
J Pharmacol Exp Ther; 1991 Nov; 259(2):680-6. PubMed ID: 1658307
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor regulation of NG108-15 adenylate cyclase: requirement for Na+ and GTP.
Lichtshtein D; Boone G; Blume A
J Cyclic Nucleotide Res; 1979 Oct; 5(5):367-75. PubMed ID: 521545
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
Onali P; Olianas MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
Keen M; Nahorski SR
Mol Pharmacol; 1988 Dec; 34(6):769-78. PubMed ID: 3200249
[TBL] [Abstract][Full Text] [Related]
9. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.
Waelbroeck M; Robberecht P; Chatelain P; Christophe J
J Cyclic Nucleotide Res; 1981; 7(3):173-85. PubMed ID: 7287969
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the regulatory properties of striatal and cortical adenylate cyclase.
Dokas LA; Ting SM
Neurobiol Aging; 1993; 14(1):65-72. PubMed ID: 8450935
[TBL] [Abstract][Full Text] [Related]
11. (R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptors.
Zorn SH; Duman RS; Giachetti A; Micheletti R; Giraldo E; Krogsgaard-Larsen P; Enna SJ
J Pharmacol Exp Ther; 1987 Jul; 242(1):173-8. PubMed ID: 2886636
[TBL] [Abstract][Full Text] [Related]
12. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a high-affinity GTPase in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase.
Onali P; Olianas MC; Schwartz JP; Costa E
Mol Pharmacol; 1983 Nov; 24(3):380-6. PubMed ID: 6138702
[TBL] [Abstract][Full Text] [Related]
14. Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations.
Ehlert FJ; Rathbun BE
Mol Pharmacol; 1990 Jul; 38(1):148-58. PubMed ID: 2370853
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum.
Westlind-Danielsson A; Andell S; Abens J; Bartfai T
Acta Physiol Scand; 1988 Mar; 132(3):425-30. PubMed ID: 2852438
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase.
Meeker RB; Harden TK
Mol Pharmacol; 1982 Sep; 22(2):310-9. PubMed ID: 6183568
[No Abstract] [Full Text] [Related]
17. In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor.
Eva C; Costa E
J Pharmacol Exp Ther; 1987 Sep; 242(3):888-94. PubMed ID: 2888875
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity.
Olianas MC; Onali P
J Pharmacol Exp Ther; 1991 Nov; 259(2):673-9. PubMed ID: 1941616
[TBL] [Abstract][Full Text] [Related]
19. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
Huff RA; Corcoran JJ; Anderson JK; Abou-Donia MB
J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360
[TBL] [Abstract][Full Text] [Related]
20. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
